Alan Minsk Discusses U.S. Market Entry Considerations for Israeli Life Sciences Companies on Going Global With Ilan Podcast

AGG Food & Drug practice chair Alan Minsk was recently featured on the “Going Global with Ilan” podcast, hosted by Ilan Friedman.

During the discussion, Alan addressed key legal and regulatory considerations for Israeli life sciences and technology companies entering the United States market, with a focus on FDA regulatory requirements.

For international companies expanding into the United States, early regulatory planning and alignment with FDA expectations can be the difference between a smooth market entry and significant disruption.

To watch the full episode, please click here.